专家论坛

肌少症与老年肺炎的发生及预防策略

  • 黄怡 ,
  • 杨梦 ,
  • 刘航序
展开
  • 1.海军军医大学第一附属医院呼吸与危重症医学科,上海 200433
    2.海军第九二九医院疾病预防控制科,上海 200433

收稿日期: 2023-10-24

  网络出版日期: 2024-04-28

Association between sarcopenia and pneumonia in elderly and prevention strategies

  • HUANG Yi ,
  • YANG Meng ,
  • LIU Hangxu
Expand
  • 1. Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
    2. Department of Disease Control and Prevention, No.905 Hospital of PLA Navy, Shanghai 200433, China

Received date: 2023-10-24

  Online published: 2024-04-28

摘要

肌少症与肺炎均是老年人的常见病,且与老年人生活质量及社会疾病负担密切相关。肌少症会引起老年人机体功能障碍,也会影响肺炎的发生及预后。而肺炎的发生也会增加肌少症的患病风险,或加重肌少症。本文将从肌少症与肺炎的关系展开探讨,重点关注肌少症与老年肺炎发生的发病和预后及相关预防策略,旨在减少老年肺炎引起的社会健康问题和疾病负担。

本文引用格式

黄怡 , 杨梦 , 刘航序 . 肌少症与老年肺炎的发生及预防策略[J]. 内科理论与实践, 2024 , 19(01) : 1 -5 . DOI: 10.16138/j.1673-6087.2024.01.01

Abstract

Sarcopenia and pneumonia are common diseases in the elderly. Both diseases are closely related to the quality of life and the disease burden in society. Sarcopenia can cause functional impairments and affect the occurrence and prognosis of pneumonia, and occurrence of pneumonia will also increase the risk of sarcopenia or worsen its’ condition. Our article discussed the association between sarcopenia and pneumonia, summarized the related prevention strategies, and aimed to reduce the social health problems and disease burden caused by the diseases in the elderly.

参考文献

[1] Torres A, Cilloniz C, Niederman MS, et al. Pneumonia[J]. Nat Rev Dis Primers, 2021, 7(1):25.
[2] 刘娟, 丁清清, 周白瑜, 等. 中国老年人肌少症诊疗专家共识(2021)[J]. 中华老年医学杂志, 2021, 40(8): 943-952.
[3] Altuna-Venegas S, Aliaga-Vega R, Magui?a JL, et al. Risk of community-acquired pneumonia in older adults with sarcopenia of a hospital from Callao, Peru 2010-2015[J]. Arch Gerontol Geriatr, 2019, 82:100-105.
[4] Huang S, Zhao L, Liu Z, et al. The effectiveness of the sarcopenia index in predicting septic shock and death in elderly patients with community-acquired pneumonia[J]. BMC Geriatr, 2022, 22(1):341.
[5] Huang S, Guo Y, Chen L, et al. Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia[J]. BMC Geriatr, 2022, 22(1):880.
[6] Simpson AJ, Allen JL, Chatwin M, et al. BTS clinical statement on aspiration pneumonia[J]. Thorax, 2023, 78 Suppl 1:s3-s21.
[7] Maeda K, Akagi J. Muscle mass loss is a potential predictor of 90-day mortality in older adults with aspiration pneumonia[J]. J Am Geriatr Soc, 2017, 65(1):e18-e22.
[8] McGovern J, Dolan R, Richards C, et al. Relation between body composition, systemic inflammatory response, and clinical outcomes in patients admitted to an urban teaching hospital with COVID-19[J]. J Nutr, 2021, 151(8): 2236-2244.
[9] Wang Y, Tan S, Yan Q, et al. Sarcopenia and COVID-19 outcomes[J]. Clin Interv Aging, 2023, 18:359-373.
[10] Piotrowicz K, G?sowski J, Michel JP, et al. Post-COVID-19 acute sarcopenia[J]. Aging Clin Exp Res, 2021, 33(10):2887-2898.
[11] Grund S, Bauer JM. Malnutrition and sarcopenia in COVID-19 survivors[J]. Clin Geriatr Med, 2022, 38(3):559-564.
[12] Machida N, Tohara H, Hara K, et al. Effects of aging and sarcopenia on tongue pressure and jaw-opening force[J]. Geriatr Gerontol Int, 2017, 17(2):295-301.
[13] Mori T, Izumi S, Suzukamo Y, et al. Ultrasonography to detect age-related changes in swallowing muscles[J]. Eur Geriatr Med, 2019, 10(5):753-760.
[14] Okazaki T, Ebihara S, Mori T, et al. Association between sarcopenia and pneumonia in older people[J]. Geriatr Gerontol Int, 2020, 20(1):7-13.
[15] Buchman AS, Boyle PA, Wilson RS, et al. Respiratory muscle strength predicts decline in mobility in older persons[J]. Neuroepidemiology, 2008, 31(3):174-180.
[16] Buchman AS, Boyle PA, Wilson RS, et al. Pulmonary function, muscle strength and mortality in old age[J]. Mech Ageing Dev, 2008, 129(11):625-631.
[17] Nelke C, Dziewas R, Minnerup J, et al. Skeletal muscle as potential central link between sarcopenia and immune senescence[J]. EBioMedicine, 2019, 49:381-388.
[18] Stana F, Vujovic M, Mayaki D, et al. Differential regulation of the autophagy and proteasome pathways in skeletal muscles in sepsis[J]. Crit Care Med, 2017, 45(9):e971-e979.
[19] Li CW, Yu K, Shyh-Chang N, et al. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention[J]. J Cachexia Sarcopenia Muscle, 2019, 10(3):586-600.
[20] Li ZJ, Zhang HY, Ren LL, et al. Etiological and epidemiological features of acute respiratory infections in China[J]. Nat Commun, 2021, 12(1):5026.
[21] Scheeren B, Gomes E, Alves G, et al. Chest CT findings in patients with dysphagia and aspiration: a systematic review[J]. J Bras Pneumol, 2017, 43(4):313-318.
[22] 佘君, 丁建文, 申捷, 等. 成人吸入性肺炎诊断和治疗专家建议[J]. 国际呼吸杂志, 2022, 42(2):86-96.
[23] Liu X, Xia X, Hu F, et al. Nutrition status mediates the association between cognitive decline and sarcopenia[J]. Aging (Albany NY), 2021, 13(6):8599-8610.
[24] 中国老年医学会营养与食品卫生分会, 中国循证医学中心,《中国循证医学杂志》编辑委员会, 等. 老年患者家庭营养管理中国专家共识(2017版)[J]. 中国循证医学杂志, 2017, 17(11): 1251-1259.
[25] Bauer J, Morley JE, Schols AMWJ, et al. Sarcopenia: a time for action[J]. J Cachexia Sarcopenia Muscle, 2019, 10(5):956-961.
[26] Cawood AL, Walters ER, Smith TR, et al. A review of nutrition support guidelines for individuals with or recovering from COVID-19 in the community[J]. Nutrients, 2020, 12(11):3230.
[27] Beaudart C, Buckinx F, Rabenda V, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power[J]. J Clin Endocrinol Metab, 2014, 99(11):4336-4345.
[28] Kirwan R, McCullough D, Butler T, et al. Sarcopenia during COVID-19 lockdown restrictions[J]. Geroscience, 2020, 42(6):1547-1578.
[29] Smith GI, Julliand S, Reeds DN, et al. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults[J]. Am J Clin Nutr, 2015, 102(1):115-122.
[30] Aguiar AF, Januário RS, Junior RP, et al. Long-term creatine supplementation improves muscular performance during resistance training in older women[J]. Eur J Appl Physiol, 2013, 113(4):987-996.
[31] Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for sarcopenia (ICFSR)[J]. J Nutr Health Aging, 2018, 22(10):1148-1161.
[32] Chambers TL, Burnett TR, Raue U, et al. Skeletal muscle size, function, and adiposity with lifelong aerobic exercise[J]. J Appl Physiol (1985), 2020, 128(2):368-378.
[33] Webber BJ, Yun HC, Whitfield GP. Leisure-time physical activity and mortality from influenza and pneumonia: a cohort study of 577 909 US adults[J]. Br J Sports Med, 2023, 57(19):1231-1237.
[34] Song Y, Ren F, Sun D, et al. Benefits of exercise on influenza or pneumonia in older adults[J]. Int J Environ Res Public Health, 2020, 17(8):2655.
[35] Tournadre A, Pereira B, Dutheil F, et al. Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis[J]. J Cachexia Sarcopenia Muscle, 2017, 8(4):639-646.
[36] Hanna MG, Badrising UA, Benveniste O, et al. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT)[J]. Lancet Neurol, 2019, 18(9):834-844.
文章导航

/